Masakatsu Fukuda,Yudai Ogasawara,Hiroyasu Hayashi,Ayako Okuyama,Junya Shiono,Katsuyuki Inoue,Hideaki Sakashita,MASAKATSU FUKUDA,YUDAI OGASAWARA,HIROYASU HAYASHI,AYAKO OKUYAMA,JUNYA SHIONO,KATSUYUKI INOUE,HIDEAKI SAKASHITA

Abstract:BACKGROUND/AIM: This study aimed to elucidate the role of glutathione peroxidase 4 (GPX4) on the sterol regulatory element binding proteins (SREBPs)-proliferation pathway in oral cancer cells, and determine its protein expression in oral cancer tissues.MATERIALS AND METHODS: Quantitative RT-PCR and immunoblot analysis were carried out. Cell viability assay, apoptosis detection assay, immunohistochemistry and GPX4 knockdown were performed.RESULTS: The levels of both GPX4 mRNA and protein were highest in SAS cells. GPX4 knockdown in SAS cells, a human oral squamous cell carcinoma cell line, using GPX4 siRNA resulted in a reduction in cell number, which appeared to be due to non-apoptotic cell death such as ferroptosis. Furthermore, SREBP was clearly down-regulated by GPX4 knockdown in SAS cells. Immunopositivity for GPX4 was revealed on the membrane of human oral squamous cell carcinoma cells, and this was correlated with p53 immunoreactivity.CONCLUSION: GPX4 appears to play an important role in oral cancer proliferation.

Down-regulation of Glutathione Peroxidase 4 in Oral Cancer Inhibits Tumor Growth Through SREBP1 Signaling